Skip to main content

Advertisement

Log in

Adrenocortical carcinoma: effect of hospital volume on patient outcome

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Optimal management of adrenocortical carcinoma (ACC) involves a detailed diagnostic workup, radical surgery, and appropriate adjuvant therapy. However, due to the rarity of this disease, adequate expertise is necessary to ensure optimal patient care. We evaluated if the experience of a treating center influences the outcome of ACC.

Methods

Two hundred sixty-three patients who underwent adrenalectomy for ACC were included in a multi-institutional surgical survey and divided into 2 groups: “high-volume center” (HVC) (≥10 adrenalectomies for ACC) and “low-volume center” (LVC) (<10 adrenalectomies for ACC). A comparative analysis was performed.

Results

One hundred seventy-two patients underwent adrenalectomy at HVC and 91 at LVC. The two groups were homogeneous for age, sex, clinical presentation, and stage. The mean lesions size of ACC was higher in HVC than in LVC (104.1 ± 54.6 vs 82.8 ± 41.3 mm; P < 0.001). A significantly higher rate of lymph node dissection (P < 0.01) and of multiorgan resection (P < 0.01) was accomplished in HVC. The number of patients who underwent adjuvant therapy was significantly higher in HVC (P < 0.001). Local recurrence rate was lower in patients treated at HVC (6% vs 18.5%; P = NS). Mean time to recurrence was significantly longer in HVC than in LVC (25.2 ± 28.1 vs 10.1 ± 7.5; P < 0.01).

Conclusion

The expertise of dedicated centers had a positive impact on the outcome of patients with ACC, resulting in a lower recurrence rate and improved mean time to recurrence. The improved patient outcome could be related not only to the appropriateness of the surgical procedure, but also to a more adequate multidisciplinary approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dackiw APB, Lee JE, Gagel RF, Evans DB (2001) Adrenal cortical carcinoma. World J Surg 25:914–926

    Article  PubMed  CAS  Google Scholar 

  2. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jaques DP, Brennan MF (2002) Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 20:941–950

    Article  PubMed  CAS  Google Scholar 

  3. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667–680

    Article  PubMed  CAS  Google Scholar 

  4. Libè R, Fratticci A, Bertherat J (2007) Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 14:13–28

    Article  PubMed  Google Scholar 

  5. Fassnacht M, Allolio B (2009) Clinical management of adrenocortical carcinoma. Best Prac Res Clin Endocrinol Metab 2:273–289

    Article  Google Scholar 

  6. Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P, The ACC Italian Registry Study Group (1996) The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. Surgery 119:161–170

    Article  PubMed  CAS  Google Scholar 

  7. Schulick RD, Brennan MF (1999) Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6:719–726

    Article  PubMed  CAS  Google Scholar 

  8. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 25:891–897

    Article  PubMed  CAS  Google Scholar 

  9. Vassilopoulou-Sellin R, Schultz PN (2001) Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92:1113–1121

    Article  PubMed  CAS  Google Scholar 

  10. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650–2655

    Article  PubMed  CAS  Google Scholar 

  11. Bellantone R, Ferrante A, Boscherini M, Lombardi CP, Crucitti P, Crucitti F, Favia G, Borrelli D, Boffi L, Capussotti L, Carbone G, Casaccia M, Cavallaro A, Del Gaudio A, Dettori G, Di Giovanni V, Mazziotti A, Marrano D, Masenti E, Miccoli P, Mosca F, Mussa A, Petronio R, Piat G, Marzano L et al (1997) Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 122:1212–1218

    Article  PubMed  CAS  Google Scholar 

  12. Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE (2010) Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol 17:263–270

    Article  PubMed  Google Scholar 

  13. Fassnach M, Johanssen S, Fenske W, Weismann D, Agha A, Beusclein F, Führer D, Jurowich C, Quinkler M, Petersenn S, Sphn M, Hahner S, Allolio B (2010) Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. J Clin Endocrin Metab 95:4925–4932

    Article  Google Scholar 

  14. Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113:3130–3136

    Article  PubMed  Google Scholar 

  15. Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112:963–970, discussion 970–971

    PubMed  CAS  Google Scholar 

  16. Johanssen S, Hahner S, Saeger W, Quinkler M, Beuschlein F, Dralle H, Haaf M, Kroiss M, Jurowich C, Langer P, Oelkers W, Spahn M, Willenberg HS, Mäder U, Allolio B, Fassnacht M (2010) Deficits in the management of patients with adrenocortical carcinoma in Germany. Dtsch Arztebl Int 107(50):885–891

    PubMed  Google Scholar 

  17. Park HS, Roman SA, Sosa JA (2009) Outcomes from 3144 adrenalectomies in the United States. Which matters more, surgeon volume or specialty? Arch Surg 144:1060–1067

    Article  PubMed  Google Scholar 

  18. Villar JM, Moreno P, Ortega J, Bollo E, Ramírez CP, Muñoz N, Martínez C, Domínguez-Adame E, Sancho J, del Pino JM, Couselo JM, Carrión A, Candel M, Cáceres N, Octavio JM, Mateo F, Galán L, Ramia JM, Aguiló J, Herrera F (2010) Results of adrenal surgery. Data of a Spanish national survey. Langebecks Arch Surg 395:837–843

    Article  Google Scholar 

  19. Anonymous (2002) NIH state-of-the-science statement on management of the clinically unapparent adrenal mass (“incidentaloma”). NIH Consensus State Sci Statements 19(2):1–25

  20. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484

    PubMed  CAS  Google Scholar 

  21. Macfarlane DA (1958) Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 23:155–186

    PubMed  CAS  Google Scholar 

  22. Sulivan M, Boileau M, Hodges CV (1958) Adrenal cortical carcinoma. J Urol 120:155–186

    Google Scholar 

  23. Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM (2010) Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg 34:1380–1385

    Article  PubMed  CAS  Google Scholar 

  24. Porpiglia F, Fiori C, Daffara F, Zaggia B, Bollito E, Volante M, Berutti A, Terzolo M (2010) Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur Urol 57:873–878

    Article  PubMed  Google Scholar 

  25. Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, Langer P, Mussack T, Nies C, Riedmiller H, Spahn M, Weismann D, Hahner S, Fassnacht M, German Adrenocortical Carcinoma Registry Group (2010) Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol 58:609–615

    Article  PubMed  Google Scholar 

  26. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi P, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A (2007) Adjuvant mitotane treatment in patients with adrenocortical carcinoma. N Engl J Med 356:372–380

    Article  Google Scholar 

Download references

Acknowledgments

We wish to thank Antonio Ambrosi (University of Foggia), Giuseppe Cucchiara (Hospital “Fatebenefratelli”, Rome), Giorgio Giannone (Hospital “Garibaldi - Nesima”, Catania), Gianluigi Melotti (Baggiovara Hospital, Modena), Fabio Procacciante (University “La Sapienza”, Rome), Emilio Trabucchi (University of Milano, Milan), Franco Uggeri (University of Milano Bicocca, Monza) for participating in and for their contribution in updating the Italian ACC multi-institutional surgical survey.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Raffaelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lombardi, C.P., Raffaelli, M., Boniardi, M. et al. Adrenocortical carcinoma: effect of hospital volume on patient outcome. Langenbecks Arch Surg 397, 201–207 (2012). https://doi.org/10.1007/s00423-011-0866-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-011-0866-8

Keywords

Navigation